These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 26269227)

  • 41. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A systematic review of cannabidiol trials in neurodevelopmental disorders.
    Parrella NF; Hill AT; Enticott PG; Barhoun P; Bower IS; Ford TC
    Pharmacol Biochem Behav; 2023 Sep; 230():173607. PubMed ID: 37543051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicians' Guide to Cannabidiol and Hemp Oils.
    VanDolah HJ; Bauer BA; Mauck KF
    Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current legal status of medical marijuana and cannabidiol in the United States.
    Alharbi YN
    Epilepsy Behav; 2020 Nov; 112():107452. PubMed ID: 32956945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Essential Medicinal Chemistry of Cannabidiol (CBD).
    Nelson KM; Bisson J; Singh G; Graham JG; Chen SN; Friesen JB; Dahlin JL; Niemitz M; Walters MA; Pauli GF
    J Med Chem; 2020 Nov; 63(21):12137-12155. PubMed ID: 32804502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cannabidiol pharmacotherapy for delta-9-tetrahidrocannabinol dependence].
    Pavlovsky F; Groisman R; Hurtado AK; García L
    Vertex; 2022 Oct; 33(157):34-43. PubMed ID: 36219190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges.
    Green R; Khalil R; Mohapatra SS; Mohapatra S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
    Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
    Mascal M; Hafezi N; Wang D; Hu Y; Serra G; Dallas ML; Spencer JPE
    Sci Rep; 2019 May; 9(1):7778. PubMed ID: 31123271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics.
    Buchtova T; Lukac D; Skrott Z; Chroma K; Bartek J; Mistrik M
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabidiol Adverse Effects and Toxicity.
    Huestis MA; Solimini R; Pichini S; Pacifici R; Carlier J; Busardò FP
    Curr Neuropharmacol; 2019; 17(10):974-989. PubMed ID: 31161980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CBD and THC: Do They Complement Each Other Like Yin and Yang?
    Pennypacker SD; Romero-Sandoval EA
    Pharmacotherapy; 2020 Nov; 40(11):1152-1165. PubMed ID: 33080058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management.
    Le K; Au J; Hua J; Le KDR
    Cureus; 2023 Dec; 15(12):e50634. PubMed ID: 38226097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can cannabidiol (CBD) help with low back pain?
    Kulesza B; Mazurek M; Kurzepa J
    Ann Agric Environ Med; 2023 Sep; 30(3):549-554. PubMed ID: 37772533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
    Trigo JM; Lagzdins D; Rehm J; Selby P; Gamaleddin I; Fischer B; Barnes AJ; Huestis MA; Le Foll B
    Drug Alcohol Depend; 2016 Apr; 161():298-306. PubMed ID: 26925704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
    White CM
    J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
    Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
    Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
    Chye Y; Christensen E; Solowij N; Yücel M
    Front Psychiatry; 2019; 10():63. PubMed ID: 30837904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.